Kisspeptin-10
Worth trying, BioHarmony verdict
BioHarmony score 6.5 out of 10
Kisspeptin-10 is an investigational reproductive neuropeptide that activates the HPG axis through the KISS1R receptor. Single subcutaneous kisspeptin-54 triggered egg maturation in 95 percent of women at high OHSS risk, per Abbara 2015, but kisspeptin-10 itself has thin direct human data and a minutes-long half-life.
Read full reportWhat is Kisspeptin-10?
Kisspeptin-10 is the master upstream switch for the reproductive axis, and that is the cleanest way to understand why it scores where it does. It is the minimal active fragment of kisspeptin, the natural signal that turns the whole hypothalamic-pituitary-gonadal system on. It activates the KISS1R receptor on GnRH neurons, which fire and drive the pituitary to release LH and FSH, which in turn drive your own testosterone or estradiol and gamete production. People born with a broken version of this receptor never enter puberty, which is the strongest proof you can get that this pathway is genuinely central, per Seminara 2003.
From the BioHarmony report, reviewed Sep 8, 2026.
Saved on this device only.
How it is thought to work
Agonist at KISS1R (GPR54) on GnRH neurons, driving pulsatile GnRH, then LH and FSH
Safety watch-outs
- Falling libido or hormone markers on continuous dosing, a sign of axis downregulation: stop and let the axis recover.
- Any active or hormone-sensitive cancer, or reproductive cancer history: do not use, no safety data.
- Pregnancy or attempting natural conception outside a supervised fertility setting: do not use.
- Unverified or research-chemical source with no purity or identity testing: do not inject.
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for Kisspeptin-10 yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (1)
Attributed viewpoints, separate from primary research.
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
FDA places kisspeptin-10 in 503A Category 2 and says available safety information is insufficient to determine whether proposed compounded routes would cause harm.
Primary sources
- Certain bulk drug substances for use in compounding that may present significant safety risks U.S. Food and Drug Administration,
Related peptides for gh axis & hormones
- 6.8Gonadorelin (GnRH)Gonadorelin is synthetic GnRH, a decapeptide that tells the pituitary to release LH and FSH.
- 5.4PT-141 (Bremelanotide)PT-141 (bremelanotide) is the only FDA-approved drug for low sexual desire in premenopausal women (Vyleesi, 2019).
- 6.6TB-500 (Thymosin Beta-4 Fragment)TB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
- 6.2IpamorelinIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.